Blood News and Research

RSS

Navigating the Labyrinth of Traumatic Brain Injury to Discover a Secondary Neurological Condition

Working with individuals with traumatic brain injury (TBI) every day, I see the debilitating effects and long-term struggles firsthand.

9 Oct 2012

Healthy lungs can retain age-related cognitive functions

Keeping the lungs healthy could be an important way to retain thinking functions that relate to problem-solving and processing speed in one's later years, new research suggests.

9 Oct 2012

New time-resolved multi-frame MRI technique can identify early-stage CAD

With the results of a magnetic resonance imaging (MRI) study from the National Institutes of Health (NIH), researchers say they are closer to finding an imaging technique that can identify thickening of the coronary artery wall, an early stage of coronary heart disease (CAD). The study is published online in the journal Radiology.

9 Oct 2012

Eating tomatoes associated with reduced risk of stroke

Eating tomatoes and tomato-based foods is associated with a lower risk of stroke, according to new research published in the October 9, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology. Tomatoes are high in the antioxidant lycopene.

9 Oct 2012

ARIPI trial: Fresh blood not better for acutely ill premature babies

In a finding that runs counter to commonly held beliefs about fresh being better, a clinical trial published today by the Journal of the American Medical Association shows that acutely ill premature babies who received fresher blood did not fare better than those who received the current standard of care. There was no difference between the two approaches with respect to major organ injury, mortality and infection.

9 Oct 2012

Study sheds light on fundamental cellular process

Scientists at the Gladstone Institutes have mapped the precise frequency by which genes get turned on across the human genome, providing new insight into the most fundamental of cellular processes-and revealing new clues as to what happens when this process goes awry.

9 Oct 2012

New blood test can read genetic changes in prostate cancer

Scientists have designed a blood test that reads genetic changes like a barcode - and can pick out aggressive prostate cancers by their particular pattern of gene activity.

9 Oct 2012

Boston Scientific enters definitive agreement to acquire Rhythmia Medical

Boston Scientific Corporation has entered into a definitive agreement to acquire privately-held Rhythmia Medical, Inc., a developer of next-generation mapping and navigation solutions for use in cardiac catheter ablations and other electrophysiology procedures, including atrial fibrillation and atrial flutter.

9 Oct 2012

Maths-based tool can quantify the spread and infectiousness of viruses

Mathematicians have developed a powerful tool to quantify the spread and infectiousness of viruses like the pandemic H1N1 flu strain, which can be used together with modern laboratory techniques to help the healthcare system plan its response to disease outbreaks.

9 Oct 2012

Early blood pressure control reduces future CV events in diabetes

Type 2 diabetes patients who fail to properly control their blood pressure within a year of being diagnosed with hypertension face an elevated risk for future major cardiovascular events for up to 3 years subsequently, study results show.

8 Oct 2012

Wait until infection is confirmed before starting antimicrobials in ICU

Delaying antimicrobial treatment of patients in the surgical intensive care unit who have a suspected hospital-acquired infection does not increase the risk for mortality, and may even be associated with better outcomes than starting antimicrobials before culturing blood, say researchers.

8 Oct 2012

Low-dose aspirin may protect against cognitive decline in elderly women

Elderly women at risk for cardiovascular events who take low-dose acetylsalic acid exhibit less cognitive decline on the Mini Mental State Examination than their peers who do not take the drug, report researchers.

8 Oct 2012

New neuroprotective agent for stroke patients potentially found

Scientists have shown that a drug called NA-1 results in fewer brain lesions in patients who have undergone surgery to repair a brain aneurysm, compared to placebo, and appears to be safe to use, according to an Article published Online First in The Lancet Neurology.

8 Oct 2012

ImaginAb enters into neurodegeneration research collaboration agreement with Lundbeck

ImaginAb, Inc., a clinical-stage company developing in vivo molecular imaging agents based on antibody fragment technology, today announced that it has entered into a collaboration and commercialization agreement with H. Lundbeck A/S.

8 Oct 2012

Trellis, OMT enter collaboration to generate human antibodies

Trellis Bioscience LLC and Open Monoclonal Technology, Inc. today announced a new collaboration where the companies will join forces to generate human antibodies against therapeutic targets identified by Trellis and its partners using OMT's OmniRat platform.

8 Oct 2012

Standard red blood cell transfusion as good as fresh RBCs for premature infants

Among premature, very low-birth-weight infants requiring a transfusion, use of fresh red blood cells (RBCs) compared with standard RBC transfusion practice did not improve clinical outcomes that included rates of complications or death, according to a study in the October 10 issue of JAMA.

8 Oct 2012

NCI awards Cellerant SBIR contract to develop Megakaryocyte Progenitor Cell therapy for thrombocytopenia

Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase 1 contract and a Phase 2 option from the National Cancer Institute (NCI) valued up to $1,683,503.

8 Oct 2012

Trevena reports completion of TRV027 Phase 2a study in advanced heart failure patients

Trevena, Inc., the leader in the discovery and development of G-protein coupled receptor (GPCR) biased ligands, today announced that it has successfully completed a Phase 2a study on the hemodynamic effects of TRV027 in patients with advanced heart failure with reduced ejection fraction.

8 Oct 2012

Dexcom receives FDA approval for G4 PLATINUM continuous glucose monitoring system

Dexcom, a leader in continuous glucose monitoring, announced today that the U.S. Food and Drug Administration has approved its eagerly anticipated new continuous glucose monitoring system, the Dexcom G4 PLATINUM.

8 Oct 2012